BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35379594)

  • 1. The reality of cholangiocarcinoma in India- real world data from a tertiary referral centre.
    Patkar S; Gupta V; Khobragade K; Goel M
    HPB (Oxford); 2022 Sep; 24(9):1511-1518. PubMed ID: 35379594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma miscoding in hepatobiliary centres.
    Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.
    Schramm C; Sapuk A; Hoyer D; Radünz S; Schmidt H
    Z Gastroenterol; 2024 Jan; 62(1):37-42. PubMed ID: 38195106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
    Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
    J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
    Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
    Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma.
    Lurje I; Czigany Z; Eischet S; Bednarsch J; Ulmer TF; Isfort P; Strnad P; Trautwein C; Tacke F; Neumann UP; Lurje G
    Hepatol Commun; 2022 Sep; 6(9):2400-2417. PubMed ID: 35616275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current diagnostic and management options in perihilar cholangiocarcinoma.
    Rizvi S; Gores GJ
    Digestion; 2014; 89(3):216-24. PubMed ID: 24860985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder cancer mimicking perihilar cholangiocarcinoma-considerable rate of postoperative reclassification with implications for prognosis.
    Nooijen LE; Gustafsson-Liljefors M; Erdmann JI; D'Souza MA; Gilg S; Villard C; Jansson H
    World J Surg Oncol; 2023 Sep; 21(1):286. PubMed ID: 37697321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma.
    Akita M; Sofue K; Fujikura K; Otani K; Itoh T; Ajiki T; Fukumoto T; Zen Y
    HPB (Oxford); 2019 Feb; 21(2):226-234. PubMed ID: 30170977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
    Sapisochin G; Ivanics T; Heimbach J
    Hepatology; 2022 Feb; 75(2):455-472. PubMed ID: 34859465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
    Javle M; Lee S; Azad NS; Borad MJ; Kate Kelley R; Sivaraman S; Teschemaker A; Chopra I; Janjan N; Parasuraman S; Bekaii-Saab TS
    Oncologist; 2022 Oct; 27(10):874-883. PubMed ID: 35972334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
    Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
    BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?
    Yilmaz S; Carr BI; Akbulut S
    J Gastrointest Cancer; 2022 Dec; 53(4):1104-1112. PubMed ID: 34738188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.
    Wang Y; Li K; Zhao W; Liu Z; Liu J; Shi A; Chen T; Mu W; Xu Y; Pan C; Zhang Z
    Cell Death Dis; 2021 Dec; 12(12):1158. PubMed ID: 34907179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical characteristics and mortality risk between patients with cholangiocarcinoma: A retrospective cohort study.
    Liu Y; Wang Y; Yu Y; Luo H; Zhen M; Ren J
    Front Surg; 2022; 9():1037310. PubMed ID: 36873806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
    Lee YT; Singal AG; Lauzon M; Agopian VG; Luu M; Noureddin M; Todo T; Kim IK; Friedman ML; Kosari K; Nissen NN; Roberts LR; Heimbach JK; Gores GJ; Yang JD
    Cancer; 2022 Oct; 128(20):3610-3619. PubMed ID: 35997126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
    Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S
    Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.